Introducing New Peptides for Cancer & Apoptosis Research
Expand your research and drug discovery with AnaSpec off-the-shelf peptides
As conventional cancer treatments present challenges such as resistance, and lack of selectivity, newer alternatives are being explored to provide advancements towards better clinical outcomes. Peptides offer a high potential in cancer therapy, owing to high target specificity and selectivity, with low toxicity.
Our portfolio of Cancer & Apoptosis related peptides is conveniently sub-grouped into 5 categories: Autophagy, Apoptosis & Cell Death, Cancer Immunomodulators, Cancer Targeting, and Oncogenesis.
Don't miss out on the latest tools in cancer research
Apoptosis & Cell Death
Certain peptides have the ability to trigger Apoptosis in cancer cells, which is the routine mechanism that eliminates unnecessary or damaged cells, essential for homeostasis in tissues, organs and the organism as a whole.
Cancer Immunomodulators
Peptides can act as immunomodulators by enhancing the immune response against cancer cells. In Ex vivo cell therapy, dendritic or T-cells are pulsed with tumor antigen peptide in order to illicit a stronger immune response against the tumor.
Cancer targeting (new category)
Tumor-homing peptides can specifically bind to cancer cell or tumor-associated markers, making them potential tools for directing therapeutic agents to relevant sites of action.
Custom Peptide Manufacturing
Not finding a specific peptide, or need it conjugated or dye-labeled?
